Scaffold Targeting Drug-Resistant Colon Cancers
Authors:
- 6 April 2007
- journal article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 50 (9) , 1999-2002
Abstract
We have identified five derivatives of the natural product sansalvamide A that are potent against multiple drug-resistant colon cancer cell lines. These analogs share no structural homology to current colon cancer drugs, are cytotoxic at levels on par with existing drugs treating other cancers, and demonstrate selectivity for drug-resistant colon cancer cell lines over noncancerous cell lines. Thus, we have established sansalvamide A as a privileged structure for treating multiple drug-resistant colon cancers.Keywords
This publication has 3 references indexed in Scilit:
- Synthesis and Cytotoxicity of Novel Sansalvamide A DerivativesOrganic Letters, 2005
- Colorectal cancer prevention and treatmentGastroenterology, 2000
- Mismatch repair proficiency and in vitro response to 5-fluorouracilGastroenterology, 1999